Kenneth Steadman
Impact in
- Oncology top 5%
- Drug Transport and Resistance Mechanisms
-
- Pharmacological Effects and Toxicity Studies
Papers in
-
- Histone Deacetylase Inhibitors Research 5
- Ubiquitin and proteasome pathways 2
- Oncology 13
- Drug Transport and Resistance Mechanisms 4
- Peptidase Inhibition and Analysis 4
- Colorectal Cancer Treatments and Studies 3
- Co-authors
- Susan E. Bates (10 shared papers)Robert W. Robey (6 shared papers)Orsolya Polgár (3 shared papers)Kuniaki Morisaki (2 shared papers)Prakash Mistry (1 shared paper)Yasumasa Honjo (1 shared paper)Csilla Özvegy‐Laczka (1 shared paper)Balázs Sarkadi (1 shared paper)
- Journals
- Cancer Research (5 papers)Molecular Cancer Therapeutics (3 papers)Journal of Clinical Oncology (3 papers)Cell Cycle (2 papers)Cancer Chemotherapy and Pharmacology (2 papers)
- Partner nations
- United StatesRussiaHungary
In The Last Decade
Kenneth Steadman
26 papers receiving 1.2k citations
Peers
Comparison fields: 5 of 96
- Oncology 607
- Pediatrics, Perinatology and Child Health 166
- Molecular Biology 516
- Pharmacology 62
- Infectious Diseases 120
Countries citing papers authored by Kenneth Steadman
This map shows the geographic impact of Kenneth Steadman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kenneth Steadman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kenneth Steadman more than expected).
Fields of papers citing papers by Kenneth Steadman
This network shows the impact of papers produced by Kenneth Steadman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kenneth Steadman. The network helps show where Kenneth Steadman may publish in the future.
Co-authors
The 25 scholars most cited alongside Kenneth Steadman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 29 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2004 | 309 | |
| 2 | 2005 | 198 | |
| 3 | 2005 | 184 | |
| 4 | 2009 | 65 | |
| 5 | 2007 | 57 | |
| 6 | 2018 | 54 | |
| 7 | 2009 | 44 | |
| 8 | 1987 | 37 | |
| 9 | 2010 | 37 | |
| 10 | 2015 | 35 | |
| 11 | 2015 | 26 | |
| 12 | 1986 | 25 | |
| 13 | 2009 | 24 | |
| 14 | 2007 | 21 | |
| 15 | 2014 | 20 | |
| 16 | 2008 | 17 | |
| 17 | 2013 | 15 | |
| 18 | 2024 | 6 | |
| 19 | 2006 | 4 | |
| 20 | 1989 | 4 |
About Kenneth Steadman
Kenneth Steadman is a scholar working on Molecular Biology, Oncology, Pulmonary and Respiratory Medicine, Pathology and Forensic Medicine and Cardiology and Cardiovascular Medicine, having authored 29 papers that have together received 1.2k indexed citations. Recurring topics across this work include Histone Deacetylase Inhibitors Research (5 papers), Drug Transport and Resistance Mechanisms (4 papers), Peptidase Inhibition and Analysis (4 papers), Cardiac electrophysiology and arrhythmias (3 papers), Colorectal Cancer Treatments and Studies (3 papers), Lung Cancer Treatments and Mutations (3 papers), Ubiquitin and proteasome pathways (2 papers) and Cancer Genomics and Diagnostics (2 papers). The work is most often cited by research in Oncology (607 citations), Pediatrics, Perinatology and Child Health (166 citations), Molecular Biology (516 citations), Pharmacology (62 citations) and Infectious Diseases (120 citations). Kenneth Steadman has collaborated with scholars based in United States, Russia and Hungary. Frequent co-authors include Susan E. Bates, Robert W. Robey, Orsolya Polgár, Kuniaki Morisaki, Prakash Mistry, Yasumasa Honjo, Csilla Özvegy‐Laczka, Balázs Sarkadi, Randolph E. Patterson and Edith Speir. Their work appears in journals such as Cancer Research, Molecular Cancer Therapeutics, Journal of Clinical Oncology, Cell Cycle and Cancer Chemotherapy and Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.